Work

Supplementary Table S1 from Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic Transformation

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Table S1. Pre-ranked GSEA statistics between mutant and wild-type CALR 24 hours post-IL-3 withdrawal amongst STAT5, STAT3 and JAK2 inhibitor signatures from MSiGDB and literature.

DOI: 10.1158/2159-8290.22531494

Authors: Shannon Elf, Nouran S. Abdelfattah, Edwin Chen, Javier Perales-Patón, Emily A. Rosen, Amy Ko, Fabian Peisker, Natalie Florescu, Silvia Giannini, Ofir Wolach, Elizabeth A. Morgan, Zuzana Tothova, Julie-Aurore Losman, Rebekka K. Schneider, Fatima Al-Shahrour, Ann Mullally

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362539266

Cites:

Cited by:

Related to: 10